Viral load in HCV RNA—positive pregnant women

OBJECTIVES:The risk of hepatitis C virus (HCV) infection in the newborn is estimated to be around 5%, but becomes very high in the case of coinfection with HIV. One of the main factors associated with the vertical transmission of HCV is the viral load. Our objective was to investigate the behavior of HCV viral load during pregnancy in relation to HIV coinfection, liver enzymes, and vertical transmission.METHODS:Three thousand seven hundred forty-eight women seen consecutively in their first trimester of pregnancy were screened for HCV infection. Sixty-five were found to be anti-HCV+/HCV RNA+ and were followed up with clinical and serological assessment (i.e., transaminases and quantitative polymerase chain reaction [PCR] for viral load) in their second and third trimesters and 6 months after delivery. All were anti-HIV and hepatitis B surface antigen negative. HCV RNA was 12.0 ± 19.9 × 106 copies/ml in the first trimester and 10.9 ± 13.3 × 106 in the second, but increased to 19.5 ± 25.1 × 106 in the third trimester. Six months after delivery the viral load returned to the baseline levels; the changes in viral load did not reach any statistical significance, however. Transaminases tended toward a reduction from the baseline during the second and third trimesters, and then an increase in both AST and ALT was recorded 6 months after delivery. However, when the group whose AST/ALT were found abnormal at the first test was considered, no significant changes were recorded during the follow-up. The overall rate of vertical transmission was 4.6%.CONCLUSIONS:With HCV+ mothers monitoring transaminases during pregnancy is unnecessary, and testing liver enzymes at the beginning of pregnancy is sufficient. Qualitative PCR should be done once during the pregnancy, but any staging of the liver disease should be taken after delivery. Quantitative PCR testing is expensive and pointless. Any decision for elective cesarean section in HCV RNA+ mothers should be confirmed by other studies.

[1]  D. Gibb,et al.  Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission , 2000, The Lancet.

[2]  E. Tanzi,et al.  Dominant Role of Host Selective Pressure in Driving Hepatitis C Virus Evolution in Perinatal Infection , 2000, Journal of Virology.

[3]  D. Prati,et al.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women , 2000, Hepatology.

[4]  P. Marcellin,et al.  Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. , 2000, Journal of hepatology.

[5]  P. Pontisso,et al.  Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity? , 1999, Hepatology.

[6]  E. Tanzi,et al.  A Prospective Study on Mother-to-Infant Transmission of Hepatitis C Virus , 1999, Intervirology.

[7]  J. Goedert,et al.  Hepatitis C Virus Infection in the Mothers and Infants Cohort Study , 1998, Pediatrics.

[8]  Women,et al.  Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. , 1998, The Journal of infectious diseases.

[9]  M. Chang Mother‐to‐infant transmission of hepatitis C virus , 1995 .

[10]  A. Floreani,et al.  Hepatitis C virus infection in pregnancy , 1995, British journal of obstetrics and gynaecology.

[11]  M. Urdea,et al.  Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level , 1995, Hepatology.

[12]  E. Tanzi,et al.  Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population , 1995, The Pediatric infectious disease journal.

[13]  S. Mishiro,et al.  Transmission of Hepatitis C Virus From Mothers to Infants , 1994 .

[14]  N. Hayashi,et al.  Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels , 1994, Hepatology.

[15]  P. Marcellin,et al.  Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors. , 1994, Journal of hepatology.

[16]  J. Pawlotsky,et al.  Lack of mother‐to‐infant transmission of hepatitis C virus in human immunodeficiency virus–seronegative women: A prospective study with hepatitis C virus RNA testing , 1993, Hepatology.

[17]  T. Dondero,et al.  Serosurveillance of human immunodeficiency virus infection. , 1991, American journal of public health.

[18]  O. Gill,et al.  Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. , 1986, European journal of epidemiology.